Compare
Escalon Medical Corp vs CapsoVision, Inc vs Nuwellis, Inc. vs QT Imaging Holdings, Inc.
| Latest fiscal year | Escalon Medical Corp ESMC | CapsoVision, Inc CV | Nuwellis, Inc. NUWE | QT Imaging Holdings, Inc. QTI |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $12.05M | $13.55M | $8.27M | $18.93M |
| Revenue growth (YoY) | +0.5% | +15.3% | -5.4% | +287.9% |
| Gross margin | 45.7% (computed) | 52.9% | 62.0% | 45.4% |
| Operating margin | 1.1% | -188.3% | -134.3% | -23.4% |
| Net margin | 0.9% | -186.8% | -211.9% | -111.4% |
| Net income | $105.5K | -$25.32M | -$17.52M | -$21.08M |
| EPS (Diluted) | $0.00 | -$1.03 | -$25.39 | -$2.01 |
| Operating cash flow | $380.7K | -$22.86M | -$10.81M | -$8.96M |
| Free cash flow | $376.8K | -$22.95M | -$10.90M | -$9.08M |
| Cash & equivalents | $545.8K | n/a | $1.08M | $10.41M |
| Total assets | $4.99M | $18.16M | $6.12M | $23.02M |
| Total liabilities | $3.08M | $4.90M | $3.49M | $16.58M |
| Shareholders' equity | $1.92M | $13.26M | $2.62M | $6.45M |
| Return on year-end equity | 5.5% | -190.9% | -667.7% | -327.1% |
| Shares outstanding | 7.42M | 46.87M | 1.69M | 11.90M |
Revenue, most recent five fiscal years
| Fiscal year | Escalon Medical Corp | CapsoVision, Inc | Nuwellis, Inc. | QT Imaging Holdings, Inc. |
|---|---|---|---|---|
| Latest | $12.05M Ended 2025-06-30 | $13.55M Ended 2025-12-31 | $8.27M Ended 2025-12-31 | $18.93M Ended 2025-12-31 |
| 1 year earlier | $11.98M Ended 2024-06-30 | $11.76M Ended 2024-12-31 | $8.74M Ended 2024-12-31 | $4.88M Ended 2024-12-31 |
| 2 years earlier | $12.18M Ended 2023-06-30 | n/a | $8.86M Ended 2023-12-31 | $40.4K Ended 2023-12-31 |
| 3 years earlier | $10.70M Ended 2022-06-30 | n/a | $8.54M Ended 2022-12-31 | n/a |
| 4 years earlier | $10.47M Ended 2021-06-30 | n/a | $7.92M Ended 2021-12-31 | n/a |